rs587784505
Variant summary
Our verdict is Pathogenic. The variant received 15 ACMG points: 15P and 0B. PM2PP2PP3_StrongPP5_Very_Strong
The NM_006086.4(TUBB3):c.292G>A(p.Gly98Ser) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Consequence
NM_006086.4 missense
Scores
Clinical Significance
Conservation
Publications
- complex cortical dysplasia with other brain malformations 1Inheritance: AD Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, G2P, Labcorp Genetics (formerly Invitae), Illumina
- fibrosis of extraocular muscles, congenital, 3A, with or without extraocular involvementInheritance: AD Classification: STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae), Genomics England PanelApp
- congenital fibrosis of extraocular musclesInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- tubulinopathy-associated dysgyriaInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 15 ACMG points.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| TUBB3 | ENST00000315491.12 | c.292G>A | p.Gly98Ser | missense_variant | Exon 4 of 4 | 1 | NM_006086.4 | ENSP00000320295.7 | ||
| ENSG00000198211 | ENST00000556922.1 | c.1333G>A | p.Gly445Ser | missense_variant | Exon 5 of 5 | 2 | ENSP00000451560.1 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome Cov.: 31
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
Complex cortical dysplasia with other brain malformations 1 Pathogenic:3Uncertain:1
- -
The variant NM_006086.4:c.292G>A (p.Gly98Ser) results in a glycine-to-serine substitution at codon 98. According to ACMG/AMP guidelines, this variant meets the criteria for PM1, PP2, PM2, PP3, and PP5, supporting its classification as likely pathogenic. -
- -
Same nucleotide change resulting in same amino acid change has been previously reported as de novoo in similarly affected indivisual (PMID: 26639658, PS2). The variant was observed as assumed (i.e. paternity and maternity not confirmed) de novoo (3billion dataset, PM6). It is not observed in the gnomAD v2.1.1 dataset (PM2). In silico tool predictions suggest damaging effect of the variant on gene or gene product (REVEL: 0.908, 3Cnet: 0.938, PP3). Therefore, this variant is classified as likely pathogenic according to the recommendation of ACMG/AMP guideline. -
not provided Pathogenic:2
Not observed in large population cohorts (gnomAD); Missense variants in this gene are often considered pathogenic (HGMD); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 20301522, 26934450, 32169460, 32705776, 33726816, 20829227, 26639658, 33604570) -
- -
Intellectual disability Pathogenic:1
- -
TUBB3-related disorder Pathogenic:1
The TUBB3 c.292G>A variant is predicted to result in the amino acid substitution p.Gly98Ser. This variant was reported in patients with Congenital fibrosis of the extraocular muscles 3 and cortical development malformations (Whitman et al 2016. PubMed ID: 26639658; Smith SC et al 2020. PubMed ID: 32705776; Stutterd CA et al 2020. PubMed ID: 33604570; Stranneheim H et al 2021. PubMed ID: 33726816) and it occurred de novo in the patients (Whitman et al 2016. PubMed ID: 26639658; Smith SC et al 2020. PubMed ID: 32705776; Stranneheim H et al 2021. PubMed ID: 33726816). This variant has not been reported in a large population database (http://gnomad.broadinstitute.org), indicating this variant is rare. This variant is interpreted as likely pathogenic. -
Fibrosis of extraocular muscles, congenital, 3A, with or without extraocular involvement;C3808397:Complex cortical dysplasia with other brain malformations 1 Other:1
Variant classified as Pathogenic and reported on 11-08-2022 by Children's Hospital of Philadelphia. Assertions are reported exactly as they appear on the patient provided laboratory report. GenomeConnect does not attempt to reinterpret the variant. The IDDRC-CTSA National Brain Gene Registry (BGR) is a study funded by the U.S. National Center for Advancing Translational Sciences (NCATS) and includes 13 Intellectual and Developmental Disability Research Center (IDDRC) institutions. The study is led by Principal Investigator Dr. Philip Payne from Washington University. The BGR is a data commons of gene variants paired with subject clinical information. This database helps scientists learn more about genetic changes and their impact on the brain and behavior. Participation in the Brain Gene Registry requires participation in GenomeConnect. More information about the Brain Gene Registry can be found on the study website - https://braingeneregistry.wustl.edu/. -
Fibrosis of extraocular muscles, congenital, 3A, with or without extraocular involvement Other:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at